As the head of My ObGyn, Dr. Lisa Colon has done extensive research on body-contouring and fat-reducing technologies. Now, she’s identified a system she can wholeheartedly recommend. It’s called TruSculpt, a heat-based procedure that is scientifically verified, FDA-approved, and offers powerful, lasting results.
- Highly effective with no downtime –TruSculpt is a simple solution for women who want to tighten skin, decrease unwanted fat, and reduce the appearance of cellulite. This outpatient procedure requires no anesthesia, no pain medications, and little or no downtime. Usually, patients can resume everyday activities right away.
- Amazing “fat dissolving” technology – TruSculpt utilizes RF (radio frequency) technology that pulses waves of heat through the skin and into the fat cells. The fat in the cells is heated up and melted away. Depending on the size of the treatment area, fat reduction is usually achieved in 2 or 3 sessions, spaced 4-8 weeks apart.
- Safe, comfortable and non-invasive – TruSculpt is a topical procedure performed inside the physician’s office using a handheld tool. No incisions are required. The heat from the handheld tool penetrates just 7-15 millimeters below the skin. It’s very gentle for the patient, yet extremely efficient in getting rid of cellular fat.
- The science backs it up – According to numerous studies, TruSculpt has been shown to remove fat and shrink the size of fat cells. This shrinking effect continues well past the completion of the actual session. TruSculpt was also proven to boost the speed of metabolism and elimination, helping flush dead fat cells from the body.
At My ObGyn, Dr. Colon has made the decision to include TruSculpt in our My Skin and Body line of services. For more information about TruSculpt, or to schedule an initial consultation with Dr. Colon, call our office. We’d be happy to answer any questions you might have about this easy and painless procedure.
*Usually, patients have a BMI of 30 or less. Those who cannot receive TruSculpt treatments include: pregnant women; people with pacemakers or internal defibrillators; people with malignant or benign tumors in the target area; people with metallic implants in the target area